{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:55Z","timestamp":1793500135584,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jchf.2025.102573","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:46:49Z","timestamp":1758628009000},"page":"102573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-5461","authenticated-orcid":false,"given":"Pedro","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoforos K.","family":"Travlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Matias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Mavrakanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Joza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102573_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib2","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib3","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cardfail.2023.03.017","article-title":"Increased risk of heart failure hospitalization with GLP-1 receptor agonists in patients with reduced ejection fraction: a meta-analysis of the EXSCEL and FIGHT trials","volume":"29","author":"Neves","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib5","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","author":"Packer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102573_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)\u2014a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgad398","article-title":"Glucagon-like peptide 1 receptor agonists across the spectrum of heart failure","volume":"109","author":"Ferreira","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jchf.2025.102573_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102573_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010966","article-title":"Epicardial fat paradox and differential effects of GLP-1 receptor agonists across heart failure phenotypes","volume":"16","author":"Banerjee","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2015.07.015","article-title":"Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"110","author":"Sun","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jchf.2025.102573_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jchf.2025.102573_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcjd.2019.09.003","article-title":"Mechanisms by which glucagon-like-peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors reduce cardiovascular risk in adults with type 2 diabetes mellitus","volume":"44","author":"Sharma","year":"2020","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jchf.2025.102573_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2308353","article-title":"Cardiac implantable electronic devices","volume":"390","author":"Al-Khatib","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102573_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejheart.2008.08.011","article-title":"Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure","volume":"10","author":"Landolina","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacasi.2022.05.002","article-title":"Cause of death among patients with diabetes and heart failure with reduced ejection fraction","volume":"2","author":"Sharma","year":"2022","journal-title":"JACC Asia"},{"key":"10.1016\/j.jchf.2025.102573_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ejhf.1192","article-title":"Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes","volume":"20","author":"Sharma","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib20","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jchf.2025.102573_bib21","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.2337\/dc15-1437","article-title":"Effects of GLP-1 receptor agonists on heart rate and the autonomic nervous system using Holter electrocardiography and power spectrum analysis of heart rate variability","volume":"39","author":"Nakatani","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2025.102573_bib22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","article-title":"The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction","volume":"36","author":"Floras","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102573_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.004969","article-title":"Chronotropic incompetence in chronic heart failure: a state-of-the-art review","volume":"11","author":"Zweerink","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/ehu401","article-title":"Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program","volume":"36","author":"Vazir","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102573_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.1682","article-title":"Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction","volume":"22","author":"Docherty","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib26","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehae718","article-title":"Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study","volume":"45","author":"van Loon","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102573_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jamacardio.2023.5500","article-title":"\u03b2-Blocker withdrawal and functional capacity improvement in patients with heart failure with preserved ejection fraction","volume":"9","author":"Palau","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102573_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/dom.14862","article-title":"Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: a post hoc analysis of the FIGHT trial","volume":"25","author":"Neves","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jchf.2025.102573_bib29","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102573_bib30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.102573_bib31","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2017.09.002","article-title":"Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise","volume":"70","author":"Lavie","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102573_bib32","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ehf2.12334","article-title":"Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial","volume":"5","author":"Sharma","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib33","article-title":"Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: the EXSCEL trial","author":"Neves","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102573_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102573_bib35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2024.06.026","article-title":"Should the SELECT trial make us comfortable using GLP-1 receptor agonists in HFrEF?","volume":"84","author":"Neves","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925005013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925005013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:42Z","timestamp":1793496582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925005013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213177925005013"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102573","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102573"}}